The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Concentra Group (CON) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Concentra Group is one of 1003 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Concentra Group (CON) , which belongs to the Zacks Medical Services industry, could be a great candidate to consider.This provider of occupational health services has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 4.51%.For the last reported quart ...

Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores ...

Concentra Group (CON) has been beaten down lately with too much selling pressure. While the stock has lost 8.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that ...

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revisi ...

Concentra Group Holdings Parent (CON) Q4 2024 Earnings Call March 04, 2025 06:01 PM ET Company Participants Keith Newton - CEOMatthew DiCanio - President & CFOBenjamin Rossi - Equity Research AssociateMichael Murray - Equity Research Associate Conference Call Participants Jamie Perse - Equity Research AnalystStephen Baxter - Senior Equity Research AnalystJustin Bowers - AnalystJoanna Gajuk - Equity Research Analyst Operator Good morning, and thank you for joining us today for Concentra Group Holdings Parent ...

NEW YORK, March 4, 2025 /PRNewswire/ -- Consolidated Edison, Inc. ("Con Edison") (NYSE: ED) announced today it has agreed to issue 6,300,000 of its common shares.  These common shares are being offered by Barclays under Con Edison's effective shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The underwriter may offer the common shares in transactions on the New York Stock Exchange LLC, in the over-the-counter market or through negotiated transactions at market price ...

Debt and Financial Obligations - The company has significant covenants in its credit agreement, including limitations on mergers, asset sales, and indebtedness, which are tested quarterly [229]. - Failure to comply with covenants could lead to an event of default, resulting in immediate repayment of all borrowings and accrued interest [230]. - The company's ability to repay its debt is dependent on cash flow generated by its subsidiaries, which may face legal and contractual restrictions [231]. - The company may incur additional indebtedness despite existing restrictions, potentially increasing financial risks in a rising interest rate environment [232]. - Rising interest rates could lead to increased operating costs, negatively impacting net income [233]. - The company may face challenges in refinancing its debt on favorable terms, which could adversely affect its financial condition [234]. - Credit rating downgrades could increase borrowing costs and reduce access to capital markets [235]. - The company is a holding entity, relying on subsidiaries for cash flow, and any inability of these subsidiaries to pay dividends could impact the company's financial obligations [268]. - The company cannot guarantee future dividends on common stock, as these depend on cash received from subsidiaries and various legal and financial conditions [269]. - The company has not adopted a written dividend policy, and the declaration of dividends is at the discretion of the Board [269]. - As of December 31, 2024, the company had outstanding borrowings under credit facilities consisting of an $847.9 million term loan [387]. - A 0.25% change in market interest rates would impact the interest expense on the company's variable rate debt by approximately $2.1 million per year [388]. Operational Challenges - The separation from Select may not yield all expected benefits, potentially affecting the company's financial condition and operations [239]. - The company is subject to significant restrictions on corporate transactions for two years post-separation to maintain tax-free status, limiting strategic flexibility [243]. - The company may face increased costs in its supply chain due to decreased purchasing power following the Separation from Select [247]. - The company is relying on SMC to fulfill its obligations under the Transition Services Agreement, which could impact costs and operational flexibility if not performed adequately [249]. - The company has joint and several liability with Select for consolidated U.S. federal income taxes for periods prior to the Distribution, which could affect financial obligations [254]. - The company may not be able to obtain services at favorable terms compared to those available prior to the Separation, potentially increasing costs and reducing profitability [247]. - The company is in the process of creating its own systems and services to replace those currently provided by SMC, which may be complex and costly [250]. - The company has potential indemnification obligations to SMC that could result in substantial liabilities, adversely affecting financial condition [252]. - The company faces significant demands on management due to obligations under the Securities Exchange Act and Sarbanes-Oxley Act, which could adversely affect business operations [265]. - The company’s operations could be disrupted by the loss of key management personnel, affecting business strategy execution [279]. - The company’s ability to attract and retain skilled employees is critical, and challenges in the labor market could adversely affect operations [280]. Market and Stock Performance - The market price of the company's common stock may be highly volatile, influenced by various external factors beyond its control [258]. - The company cannot assure that an active trading market for its common stock will be sustained, which could impair capital raising efforts [257]. - The company has provisions in its bylaws that may deter hostile takeovers, which could impact stock price and shareholder interests [272]. Regulatory and Compliance Risks - The company may face conflicts of interest due to shared executive officers and directors with Select, impacting decision-making [248]. - The agreements with Select and SMC may not reflect terms that would have resulted from arm's-length negotiations, potentially affecting service costs [256]. - Climate change and related regulations could negatively impact the company’s operations and financial condition [283]. - Increasing scrutiny regarding ESG practices may create new obligations and affect the company’s business performance [284]. Financial Reporting and Estimates - The company has limited history as a standalone public entity, and its financial results may not reflect future performance [236]. - The company’s financial statements are subject to estimates and assumptions, and any changes in these could adversely affect operations and stock price [270].

Acquisition Details - The base purchase price for the acquisition is set at $265,000,000[29] - An adjustment basket amount of $200,000 is established for potential purchase price adjustments[18] - The agreement includes provisions for various ancillary agreements related to the transaction[25] - The closing date estimates and purchase price adjustments are outlined in the agreement[2.4] - The company is required to provide audited financial statements as part of the representations and warranties[27] - The agreement stipulates that the closing will occur on a business day, defined as any day other than Saturday, Sunday, or bank holidays in Dallas, Texas[29] - The parties involved include Concentra Health Services, Inc. as the buyer and multiple trusts as sellers[13] - The agreement includes conditions to closing that must be satisfied by all parties[7.1] - The transaction involves the transfer of all outstanding membership interests of the company from the sellers to the buyer[15] - The agreement outlines the responsibilities of the sellers' representative in the transaction[13] Financial Performance - The Company reported a significant increase in revenue, achieving $1.5 billion in Q3 2023, representing a 25% year-over-year growth[110] - The Company reported a significant increase in revenue, achieving $1.5 billion for the quarter, representing a 20% year-over-year growth[1] - User data showed a 15% increase in active users, reaching 10 million by the end of Q3 2023[110] - User data showed a total of 5 million active users, up from 4 million in the previous quarter, indicating a 25% increase[2] - The Company reported a decrease in operating expenses by 5%, improving overall profitability margins[110] - The Company reported a 15% increase in gross margin, reaching 60% for the quarter[8] - Customer retention rates improved to 85%, up from 80% in the previous quarter, reflecting enhanced customer satisfaction[9] Future Guidance and Projections - The Company provided guidance for Q4 2023, expecting revenue to be between $1.6 billion and $1.7 billion, indicating a growth rate of 20% to 30% compared to Q4 2022[110] - The Company provided guidance for the next quarter, projecting revenue between $1.6 billion and $1.7 billion, which reflects a growth rate of 7% to 13%[3] - New product launches are anticipated to contribute an additional $200 million in revenue in the next quarter[110] - New product launches are expected to contribute an additional $200 million in revenue over the next fiscal year[4] Strategic Initiatives - The Company is investing $50 million in R&D for new technologies aimed at enhancing user experience and operational efficiency[110] - The Company is investing $50 million in research and development for new technologies aimed at enhancing user experience[5] - Market expansion plans include entering three new international markets by the end of 2024, projected to increase user base by 10%[110] - Market expansion plans include entering three new countries by the end of the fiscal year, targeting a potential market of 10 million users[6] - The Company is exploring potential acquisitions to bolster its market position, with a budget of $100 million allocated for this purpose[110] - The Company is considering strategic acquisitions to bolster its market position, with a budget of $100 million allocated for potential deals[7] - A strategic partnership with a leading tech firm is expected to enhance product offerings and drive innovation[110] - The company has outlined a strategy for potential acquisitions to bolster its service offerings in occupational medicine[167] Compliance and Regulatory Matters - The company is subject to various Healthcare Laws governing provider relationships, service delivery, and healthcare operations[118] - Compliance with HIPAA regulations is critical for the management of personal health information and data security[120] - The company has established protocols for the processing and protection of Personal Information under applicable Privacy and Data Security Laws[150] - The Medicare and Medicaid programs are significant components of the company's operational framework, impacting service delivery and reimbursement[154] - The company is involved in the administration and compliance with federal healthcare programs, which includes managing claims and benefits[154] - The company has a structured approach to handle potential claims and liabilities through indemnity agreements and privacy commitments[149] - The company maintains a focus on intellectual property rights, including patents and proprietary information, to safeguard its innovations[120] - The company is committed to adhering to laws regulating the solicitation of incentives and fraud prevention in the healthcare industry[118] - The company has established guidelines for the licensing and operation of healthcare services, ensuring compliance with state and federal regulations[118] - The company is actively monitoring changes in healthcare laws that may affect its operations and strategic initiatives[118] Operational Strategies - The target net working capital is set at $15,000,000[187] - The company has established a retention program to enhance employee engagement and reduce turnover[169] - The company is focusing on expanding its market presence in Texas, Georgia, Indiana, Tennessee, and Wisconsin[168] - The company is actively pursuing research and development partnerships with governmental authorities and educational institutions[158] - The company is implementing a new software solution to improve operational efficiency in its medical services[176] - The company is committed to maintaining compliance with all relevant tax regulations and has outlined its tax obligations[188] - The company is preparing for potential tax audits and disputes to ensure financial stability[189] - The company is exploring new product offerings in travel medicine and OSHA medical programs[167] - The company has established a special indemnity escrow amount of $200,000 to manage potential liabilities[176]

Group 1 - Concentra Group (CON) has gained approximately 15.8% year-to-date, outperforming the average return of 6.3% for the Medical sector [4] - The Zacks Rank for Concentra Group is currently 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] - The Zacks Consensus Estimate for CON's full-year earnings has increased by 5.4% over the past quarter, reflecting stronger analyst sentiment [3] Group 2 - Concentra Group is part of the Medical Services industry, which consists of 59 companies and currently ranks 84 in the Zacks Industry Rank [5] - The Medical Services industry has seen an average gain of 4.3% year-to-date, indicating that Concentra Group is performing better than its industry peers [5] - Another stock in the Medical sector, Cencora (COR), has also outperformed the sector with a year-to-date return of 11.6% [4]